High-grade cervical intraepithelial lesions

Clinical trials for High-grade cervical intraepithelial lesions explained in plain language.

Never miss a new study

Get alerted when new High-grade cervical intraepithelial lesions trials appear

Sign up with your email to follow new studies for High-grade cervical intraepithelial lesions, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Experimental vaccine aims to clear precancerous cervical lesions without surgery

Disease control Not yet recruiting

This trial tests an experimental vaccine called SYS6026 in people with high-grade cervical lesions caused by HPV type 16 or 18. The goal is to see if the vaccine can help the body clear the virus and reverse the lesions, potentially avoiding the need for surgery. Participants are…

Matched conditions: HIGH-GRADE CERVICAL INTRAEPITHELIAL LESIONS

Phase 2 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control

Last updated Jul 16, 2026 00:00 UTC

High-grade cervical intraepithelial lesions

Get alerted when new High-grade cervical intraepithelial lesions trials appear

Experimental vaccine aims to clear precancerous cervical lesions without surgery